Cambridge Cognitions Holdings PLC (AIM: COG) – onwards and upwards!
Cambridge Cognition Holdings plc, (AIM: COG), which specialises in computerised neuropsychological tests including those enabling the early detection of dementia, today announced its unaudited preliminary results for the year ended 31 December 2014.
The Company is split into three divisions. Firstly, providing products and services for use in pharmaceutical clinical trials. Secondly, offering cognitive assessment products for academic research and finally, healthcare technology for use in patient and community settings. 2013 was a tough year for the Group while it underwent significant structural changes. Following these changes, 2014 has been a year of commercial focus and the Company has achieved significant growth in this time and moved into profit in the second half of the year. Total revenue was up c. 40% to £5.80m and adjusted EBITDA reduced to £0.27m loss (2013: £2.19m…